Atlas Trials

A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM)

Clinical trial NCT05403476 · TERMINATED

Trial details

NCT number
NCT05403476
Sponsor
Ferring Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Male Idiopathic Infertility
Start date
2022-08-16
Primary completion
2024-10-05
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.